garenoxacin has been researched along with oxolinic acid in 2 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (oxolinic acid) | Trials (oxolinic acid) | Recent Studies (post-2010) (oxolinic acid) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 456 | 15 | 56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W | 1 |
| Aubry, A; Cambau, E; Jarlier, V; Matrat, S | 1 |
2 other study(ies) available for garenoxacin and oxolinic acid
| Article | Year |
|---|---|
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors | 2007 |
Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?
Topics: Anti-Infective Agents; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae | 2008 |